These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 20576343)
1. The feasibility of carboplatin-based intraperitoneal chemotherapy in ovarian cancer. Kim SW; Paek J; Nam EJ; Kim SH; Kim JH; Kim YT Eur J Obstet Gynecol Reprod Biol; 2010 Oct; 152(2):195-9. PubMed ID: 20576343 [TBL] [Abstract][Full Text] [Related]
2. Alternative intraperitoneal chemotherapy regimens for optimally debulked ovarian cancer. Gray HJ; Shah CA; Swensen RE; Tamimi HK; Goff BA Gynecol Oncol; 2010 Mar; 116(3):340-4. PubMed ID: 19922987 [TBL] [Abstract][Full Text] [Related]
3. Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for Stage III ovarian cancer: a cost-effectiveness analysis. Bristow RE; Santillan A; Salani R; Diaz-Montes TP; Giuntoli RL; Meisner BC; Armstrong DK; Frick KD Gynecol Oncol; 2007 Sep; 106(3):476-81. PubMed ID: 17688927 [TBL] [Abstract][Full Text] [Related]
4. Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel. Ozols RF; Bookman MA; du Bois A; Pfisterer J; Reuss A; Young RC Gynecol Oncol; 2006 Oct; 103(1):1-6. PubMed ID: 16904166 [No Abstract] [Full Text] [Related]
5. Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study. Skarlos DV; Aravantinos G; Kosmidis P; Athanassiadis A; Stathopoulos GP; Pavlidis N; Bafaloukos D; Karphathios S; Papakostas P; Bamia C; Fountzilas G Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-57-S15-61. PubMed ID: 9346224 [TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal carboplatin and etoposide for persistent epithelial ovarian cancer: analysis of results by prior sensitivity to platinum-based regimens. Muggia FM; Groshen S; Russell C; Jeffers S; Chen SC; Schlaerth J; Curtin J; Morrow CP Gynecol Oncol; 1993 Aug; 50(2):232-8. PubMed ID: 8375739 [TBL] [Abstract][Full Text] [Related]
8. Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase III trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group. du Bois A; Lück HJ; Meier W; Möbus V; Costa S; Richter B; Warm M; Bauknecht T; Schröder W; Olbricht S; Nitz U; Jackisch C Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-44-S15-52. PubMed ID: 9346222 [TBL] [Abstract][Full Text] [Related]
9. Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with cisplatin/paclitaxel versus carboplatin/paclitaxel. Greimel ER; Bjelic-Radisic V; Pfisterer J; Hilpert F; Daghofer F; du Bois A; J Clin Oncol; 2006 Feb; 24(4):579-86. PubMed ID: 16446330 [TBL] [Abstract][Full Text] [Related]
10. Intraperitoneal therapy for ovarian cancer: why has it not become standard? Rowan K J Natl Cancer Inst; 2009 Jun; 101(11):775-7. PubMed ID: 19470952 [No Abstract] [Full Text] [Related]
11. A comparison of the toxicity and tolerability of two intraperitoneal chemotherapy regimens for advanced-stage epithelial ovarian cancer. Bouchard-Fortier G; Rosen B; Vyarvelska I; Pasetka M; Covens A; Gien LT; Kupets R; Pulman K; Ferguson SE; Vicus D Gynecol Oncol; 2016 Jan; 140(1):36-41. PubMed ID: 26546964 [TBL] [Abstract][Full Text] [Related]
12. Complications relating to intraperitoneal administration of cisplatin or carboplatin for ovarian carcinoma. Sakuragi N; Nakajima A; Nomura E; Noro N; Yamada H; Yamamoto R; Fujimoto S Gynecol Oncol; 2000 Dec; 79(3):420-3. PubMed ID: 11104613 [TBL] [Abstract][Full Text] [Related]
13. Combined cisplatin and carboplatin chemotherapy for treatment of advanced epithelial ovarian cancer. Gershenson DM; Morris M; Burke TW; Levenback C; Kavanagh JJ; Fromm GL; Silva EG; Warner D; Wharton JT Gynecol Oncol; 1995 Sep; 58(3):349-55. PubMed ID: 7672700 [TBL] [Abstract][Full Text] [Related]
14. Intraperitoneal chemotherapy for patients with advanced epithelial ovarian cancer: a review of complications and completion rates. Landrum LM; Gold MA; Moore KN; Myers TK; McMeekin DS; Walker JL Gynecol Oncol; 2008 Feb; 108(2):342-7. PubMed ID: 17988721 [TBL] [Abstract][Full Text] [Related]
15. [Significance and effects of intraperitoneal cisplatin administration for ovarian cancer]. Shimizu A; Ookubo K; Hasegawa J; Endoh T; Fujiwara O; Yoda A; Okuyama D; Narabayashi A; Kimura T; Takahashi J; Notake Y Gan To Kagaku Ryoho; 1999 Oct; 26(12):1801-5. PubMed ID: 10560398 [TBL] [Abstract][Full Text] [Related]
16. Prognostic results of cisplatin IP and carboplatin IV with G-CSF in patients with ovarian cancer. Adachi S; Itani Y; Ito K; Noda T; Shintani M; Saito K; Furukawa N; Tomii Y Oncol Rep; 2001; 8(1):27-31. PubMed ID: 11115564 [TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal chemotherapy for ovarian cancer. Ozols RF; Bookman MA; Young RC N Engl J Med; 2006 Apr; 354(15):1641-3; author reply 1641-3. PubMed ID: 16611959 [No Abstract] [Full Text] [Related]
18. High-intensity intravenous cyclophosphamide and cisplatin, interim surgical debulking, and intraperitoneal cisplatin in advanced ovarian carcinoma: a pilot trial with ten-year follow-up. Shapiro F; Schneider J; Markman M; Reichman BS; Venkatraman E; Barakat R; Almadrones L; Spriggs D Gynecol Oncol; 1997 Oct; 67(1):39-45. PubMed ID: 9345354 [TBL] [Abstract][Full Text] [Related]
19. Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma. Tournigand C; Louvet C; Molitor JL; Dehni N; Lejeune V; Sezeur A; Pigne A; Marpeau L; Cady J; de Gramont A Gynecol Oncol; 2001 Nov; 83(2):198-204. PubMed ID: 11606072 [TBL] [Abstract][Full Text] [Related]